Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

Biologics Features & News

Advertisement

A Cry for Help? FDA Bares Concerns in NEJM

Source: Pixabay

The most senior FDA executives went public with their worries, frustration even, we suspect, impotence regarding the plethora of stem cells therapies in the market last November. And that article, which appeared in the New England Journal of Medicine just keeps growing in influence. Here is what Celia Whitten, Peter Marks and Robert Califf said.